Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Silvia González Martínez"'
Autor:
Silvia González Martínez, Belén Prieto García, Ana Isabel Escudero Gomis, Elías Delgado Álvarez, Edelmiro Luis Menéndez Torre
Publikováno v:
Anales de Pediatría, Vol 97, Iss 6, Pp 375-382 (2022)
Resumen: Introducción: La TSH neonatal (TSHn) es un marcador de nutrición de yodo en la población. La OMS relaciona una prevalencia 5 mUI/L, obtenida a partir de las 72 h del nacimiento, con un adecuado estado nutricional de yodo. El objetivo de e
Externí odkaz:
https://doaj.org/article/171895763ea64efb9557f062ef3aaf46
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Single-cell RNA sequencing (scRNA-seq) technology has emerged as a powerful tool for dissecting cellular heterogeneity and understanding the intricate biology of diseases, including cancer. Endometrial cancer (EC) stands out as the most prevalent gyn
Externí odkaz:
https://doaj.org/article/718fe6b8556f45e1bef17e6ede85d4da
Autor:
Silvia González-Martínez, Eduardo Martínez-Morillo, Noelia Avello-Llano, Ana Isabel Escudero-Gomis, Elías Delgado-Álvarez, Edelmiro Luis Menéndez-Torre
Publikováno v:
Endocrinología, Diabetes y Nutrición. 70:162-170
Autor:
Julie Earl, Cristina Galindo-Pumariño, Jessica Encinas, Emma Barreto, Maria E. Castillo, Vanessa Pachón, Reyes Ferreiro, Mercedes Rodríguez-Garrote, Silvia González-Martínez, Teresa Ramon y Cajal, Luis Robles Diaz, Isabel Chirivella-Gonzalez, Montse Rodriguez, Eva Martínez de Castro, David García-Seisdedos, Gloria Muñoz, Juan Manuel Rosa Rosa, Mirari Marquez, Nuría Malats, Alfredo Carrato
Publikováno v:
EBioMedicine, Vol 53, Iss , Pp - (2020)
Background: The 5-year survival rate of patients with pancreatic ductal adenocarcinoma (PDAC) is around 5% due to the fact that the majority of patients present with advanced disease that is treatment resistant. Familial pancreatic cancer (FPC) is a
Externí odkaz:
https://doaj.org/article/d004e39611fb4b4bb0bc338bab552700
Autor:
Silvia González Martínez, Belén Prieto García, Ana Isabel Escudero Gomis, Elías Delgado Álvarez, Edelmiro Luis Menéndez Torre
Publikováno v:
Scopus
Neonatal thyroid stimulating hormone (nTSH) is a marker of iodine nutrition status in the population. The WHO considers a prevalence of less than 3% of nTSH levels greater than 5 mIU/L in samples obtained within 72h from birth indicative of iodine su
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
© 2021 García-Estevez, González-Martínez and Moreno-Bueno.
Adipose tissue secretes various peptides, including leptin. This hormone acts through the leptin receptor (Ob-R), which is expressed ubiquitously on the surface of various cells, inc
Adipose tissue secretes various peptides, including leptin. This hormone acts through the leptin receptor (Ob-R), which is expressed ubiquitously on the surface of various cells, inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af1dfe3fab6710f58c2064421167937c
http://hdl.handle.net/10261/265557
http://hdl.handle.net/10261/265557
Autor:
Belén Pérez-Mies, José Palacios, Tamara Caniego-Casas, Javier Cortés, Giuseppe Curigliano, Silvia González-Martínez, David Pizarro
Publikováno v:
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
Cancers, Vol 13, Iss 5416, p 5416 (2021)
Scientia
Cancers
Universidad Europea (UEM)
Cancers, Vol 13, Iss 5416, p 5416 (2021)
Scientia
Cancers
Simple Summary Metastasis is the last stage in the development of cancer and usually results in mortality. Cutaneous metastases (CMs) account for 2% of all skin malignancies. Nearly 70% of CMs in women originate from breast cancer (BC). Since CM is u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e73760ac977932e6d0590ed46ab0edb4
https://hdl.handle.net/11268/11375
https://hdl.handle.net/11268/11375
Autor:
José Palacios, Tamara Caniego-Casas, David Pizarro, Silvia González-Martínez, Belén Pérez-Mies, Javier Cortes
Publikováno v:
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
Scientia
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 7398, p 7398 (2021)
Universidad Europea (UEM)
Scientia
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 7398, p 7398 (2021)
Transició epitelial-mesenquimal; Carcinoma de mama metaplàstic Transición epitelio-mesenquimatosa; Carcinoma de mama metaplasico Epithelial-mesenchymal transition; Metaplastic breast carcinoma Metaplastic breast carcinoma (MBC) is a heterogeneous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::714856c46433d50f8739d396bda51fb2
https://hdl.handle.net/11268/11389
https://hdl.handle.net/11268/11389
Autor:
Silvia González-Martínez, David Pizarro, Belén Pérez-Mies, Tamara Caniego-Casas, José Luis Rodríguez-Peralto, Giuseppe Curigliano, Alfonso Cortés, María Gión, Javier Cortés, José Palacios
Publikováno v:
Cancers; Volume 14; Issue 5; Pages: 1151
Background: The characterization of molecular alterations of primary breast carcinomas (BC) and their cutaneous metastases (CM) to identify genes involved in the metastatic process have not yet been completely accomplished. Methods: To investigate th
Autor:
Reyes Ferreiro, Isabel Chirivella-Gonzalez, Vanessa Pachón, Teresa Ramón y Cajal, Jessica Encinas, Alfredo Carrato, Eva Martínez de Castro, Julie Earl, Emma Barreto, David García-Seisdedos, María E. Castillo, Mercedes Rodríguez-Garrote, Luis Robles Diaz, Juan Manuel Rosa Rosa, Montse Rodriguez, Silvia González-Martínez, Cristina Galindo-Pumariño, Núria Malats, Gloria Muñoz, Mirari Marquez
Publikováno v:
EBioMedicine
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Repisalud
Instituto de Salud Carlos III (ISCIII)
EBioMedicine, Vol 53, Iss, Pp-(2020)
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Repisalud
Instituto de Salud Carlos III (ISCIII)
EBioMedicine, Vol 53, Iss, Pp-(2020)
The 5-year survival rate of patients with pancreatic ductal adenocarcinoma (PDAC) is around 5% due to the fact that the majority of patients present with advanced disease that is treatment resistant. Familial pancreatic cancer (FPC) is a rare disorde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25622a36d563750446414eabd24db046
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1605
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1605